Viemed Healthcare (NASDAQ:VMD) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Viemed Healthcare (NASDAQ:VMD) from a buy rating to a strong-buy rating in a research note issued to investors on Saturday morning.

VMD has been the subject of a number of other reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Viemed Healthcare in a report on Monday, December 29th. Zacks Research upgraded shares of Viemed Healthcare to a “hold” rating in a research report on Thursday, January 8th. Two equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company currently has an average rating of “Hold”.

Viemed Healthcare Stock Up 1.5%

Viemed Healthcare stock opened at $8.28 on Friday. The stock has a market cap of $314.81 million, a PE ratio of 25.09 and a beta of 1.27. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.13 and a quick ratio of 1.01. The stock’s fifty day moving average is $7.56 and its two-hundred day moving average is $7.05. Viemed Healthcare has a 1-year low of $5.93 and a 1-year high of $8.94.

Institutional Investors Weigh In On Viemed Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Segall Bryant & Hamill LLC purchased a new position in shares of Viemed Healthcare during the third quarter worth about $1,965,000. Wasatch Advisors LP raised its stake in Viemed Healthcare by 18.4% during the 2nd quarter. Wasatch Advisors LP now owns 1,546,010 shares of the company’s stock valued at $10,683,000 after acquiring an additional 240,346 shares during the last quarter. Forager Capital Management LLC lifted its position in Viemed Healthcare by 12.1% during the 2nd quarter. Forager Capital Management LLC now owns 2,136,472 shares of the company’s stock worth $14,763,000 after acquiring an additional 230,670 shares during the period. Two Sigma Investments LP lifted its position in Viemed Healthcare by 193.7% during the 3rd quarter. Two Sigma Investments LP now owns 251,410 shares of the company’s stock worth $1,707,000 after acquiring an additional 165,797 shares during the period. Finally, SummerHaven Investment Management LLC purchased a new position in shares of Viemed Healthcare in the 3rd quarter valued at approximately $828,000. 74.24% of the stock is owned by hedge funds and other institutional investors.

About Viemed Healthcare

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.